Liver disease and drug therapy.
作者信息
Black M
出版信息
Med Clin North Am. 1974 Sep;58(5):1051-7. doi: 10.1016/s0025-7125(16)32100-9.
PMID:4608944
Abstract
摘要
相似文献
1
Liver disease and drug therapy.肝脏疾病与药物治疗
Med Clin North Am. 1974 Sep;58(5):1051-7. doi: 10.1016/s0025-7125(16)32100-9.
2
Clinical relevance of the effect of hepatic disease on drug disposition.肝脏疾病对药物处置影响的临床相关性。
Am J Hosp Pharm. 1978 Apr;35(4):406-14.
3
Drug metabolism in liver disease.肝脏疾病中的药物代谢
J Clin Pathol Suppl (R Coll Pathol). 1975;9:62-5.
4
[Pharmacokinetics in liver cirrhosis].[肝硬化中的药代动力学]
Z Gesamte Inn Med. 1977 Jan 1;32(1):29-33.
5
Drug disposition in liver disease.肝脏疾病中的药物处置
Am Fam Physician. 1982 Dec;26(6):167-9.
6
[Metabolism of phenylbutazone in the liver (author's transl)].
Med Klin. 1976 Sep 3;71(36):1434-8.
7
[Azathioprine pharmacokinetics in animal experiment and in patients with chronic liver diseases].[硫唑嘌呤在动物实验及慢性肝病患者中的药代动力学]
Verh Dtsch Ges Inn Med. 1973;79:943-6.
8
Drug disposition in liver disease.肝脏疾病中的药物处置
N Engl J Med. 1977 Jun 30;296(26):1527-8. doi: 10.1056/NEJM197706302962612.
9
Prediction of the disposition of nine weakly acidic and six weakly basic drugs in humans from pharmacokinetic parameters in rats.根据大鼠药代动力学参数预测九种弱酸性和六种弱碱性药物在人体内的处置情况。
J Pharmacokinet Biopharm. 1985 Oct;13(5):477-92. doi: 10.1007/BF01059331.
10
[Prescription of drugs in liver diseases].[肝脏疾病中的药物处方]
Internist (Berl). 1980 Dec;21(12):724-34.
引用本文的文献
1
Elimination of pindolol in liver disease.肝病患者中吲哚洛尔的消除情况。
Eur J Clin Pharmacol. 1982;22(3):247-51. doi: 10.1007/BF00545223.
2
Protein binding and kinetics of drugs in liver diseases.肝脏疾病中药物的蛋白结合与动力学
Clin Pharmacokinet. 1977 Jan-Feb;2(1):32-44. doi: 10.2165/00003088-197702010-00003.
Zotero 插件